🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Azacitidine can reverse clinical resistance to docetaxel through upregulati...
Status
Terminated
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2007-05
Trial ID
NCT00503984
This is a phase 1b study that follows a 3+3 dose escalation design and cons...
Status
Withdrawn
Location
Seattle Cancer Care Alliance
Start Date
2013-05
Trial ID
NCT01685489
Treatments Being Tested
The purpose of this study is to assess the relative efficacy and toxicity o...
Status
Terminated
Location
The Methodist Hospital Research Institute
Start Date
2006-12
Trial ID
NCT00450008
Treatments Being Tested
The purpose of the study is to compare safety and efficacy of a single dose...
Status
Completed
Location
Arkhangelsk District Clinical Oncology Dispensary
Start Date
2013-09
Trial ID
NCT02104830
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
1999-04
Trial ID
NCT00005800
Treatments Being Tested
The purpose of the study is to compare safety and efficacy of a single dose...
Status
Completed
Location
Arkhangelsk District Clinical Oncology Dispensary
Start Date
2012-05
Trial ID
NCT01569087
Treatments Being Tested
More than 50% of Head and Neck cancers are locally advanced at presentation...
Status
Completed
Location
Hahnemann University Hospital
Start Date
2010-03
Trial ID
NCT01467115
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as docetaxel and trabectedin, w...
Status
Completed
Location
Providence Saint Joseph Medical Center - Burbank
Start Date
2008-03
Trial ID
NCT00569673
Treatments Being Tested
This is a phase 1, open-label, multicenter, ascending-dose escalation study...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2015-02-02
Trial ID
NCT02383212